Last updated: December 3, 2024
Sponsor: Liaquat National Hospital & Medical College
Overall Status: Active - Recruiting
Phase
3
Condition
N/ATreatment
Ketamine only
Tramadol
Clinical Study ID
NCT06722742
#882-2023-LNH-ERC
Ages 18-40 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Pateint for elective cesarean section
Age 18 to 40 years
ASA 1 and 2
Exclusion
Exclusion Criteria:
ASA 2 and 3
Cesarean section requiring general anesthesia
Hypersensitivity to Ketamine, Tramadol and Opiods
History of cardiovascular disease
Study Design
Total Participants: 250
Treatment Group(s): 2
Primary Treatment: Ketamine only
Phase: 3
Study Start date:
September 30, 2024
Estimated Completion Date:
January 30, 2025
Study Description
Connect with a study center
Liaquat National Hospital and Medical College
Karachi, Sindh 75500
PakistanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.